NIRMAN AGRI GENETICS
Back to Balance Sheet
|
NIRMAN AGRI GENETICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹0.07 Cr | ₹0.03 Cr | ₹0.75 Cr | ₹1.25 Cr | ₹0.99 Cr |
What is the latest Total Non-Current Liabilities ratio of NIRMAN AGRI GENETICS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹0.07 Cr |
| Mar2024 | ₹0.03 Cr |
| Mar2023 | ₹0.75 Cr |
| Mar2022 | ₹1.25 Cr |
| Mar2021 | ₹0.99 Cr |
How is Total Non-Current Liabilities of NIRMAN AGRI GENETICS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.07 Cr | 126.67 | |
| Mar2024 | ₹0.03 Cr | -95.98 | |
| Mar2023 | ₹0.75 Cr | -40.13 | |
| Mar2022 | ₹1.25 Cr | 25.60 | |
| Mar2021 | ₹0.99 Cr | - | |
Compare Total Non-Current Liabilities of peers of NIRMAN AGRI GENETICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NIRMAN AGRI GENETICS | ₹55.7 Cr | 20.6% | 22.4% | -80.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,926.3 Cr | 4.5% | 2.7% | -15.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,597.9 Cr | 0.1% | 0.2% | -4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,032.4 Cr | -8.1% | -10.5% | -19.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹964.4 Cr | 2.1% | -8% | -43.9% | Stock Analytics | |
| INDO US BIOTECH | ₹264.5 Cr | 5% | 15.2% | -37.7% | Stock Analytics | |
NIRMAN AGRI GENETICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NIRMAN AGRI GENETICS | 20.6% |
22.4% |
-80.3% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses